Is RCKT Stock A Buy or Sell?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions...
Rocket Pharmaceuticals Inc. (RCKT)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 55,590 | $2,467 | 0% | |
| 2. | Frazier Healthcare Partners Alan Frazier | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $56.00 | 247,720 | Large Shareholder, Director | 17,530,044 | 2020-12-10 | Filing | |
| $9.50 | 1,000 | 6,675 | 2020-03-18 | Filing | ||
| $22.25 | 225,000 | Large Shareholder, Director | 17,282,324 | 2019-12-10 | Filing | |
| $17.50 | 550,005 | 17,057,324 | 2019-04-16 | Filing | ||
| $14.98 | 5,675 | 5,675 | 2018-12-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.03 | 725,000 | Large Shareholder, Director | 15,460,119 | 2021-05-11 | Filing | |
| $57.17 | 5,427 | 94,977 | 2020-12-28 | Filing | ||
| $56.51 | 11,334 | 100,404 | 2020-12-28 | Filing | ||
| $16.90 | 25,000 | 686,950 | 2019-03-05 | Filing | ||
| $17.28 | 24,900 | 711,950 | 2019-03-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 9,133 | $405,231 | 0% | |
| 2. | 3,257,640 | $144,541 | 0% | |
| 3. | 1,652,194 | $73,308 | 0.18% | |
| 4. | 1,533,879 | $68,059 | 0.02% | |
| 5. | 719,041 | $31,904 | 0% |
News See All
Is RCKT A Good Stock To Buy Now?
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
Here is What Hedge Funds Think About Rocket Pharmaceuticals, Inc. (RCKT)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 823 13F...
Hedge Funds Aren’t Crazy About Rocket Pharmaceuticals, Inc. (RCKT) Anymore
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment...
Was The Smart Money Right About Rocket Pharmaceuticals (RCKT)?
Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least 20% in (Recession is Imminent...
Did Hedge Funds Drop The Ball On Rocket Pharmaceuticals, Inc. (RCKT) ?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even...
Should You Buy Rocket Pharmaceuticals, Inc. (RCKT)?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and Microsoft ranked among the top 3 picks and these...
Here’s What Hedge Funds Think About Rocket Pharmaceuticals, Inc. (RCKT)
We at Insider Monkey have gone over 738 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Here’s What Hedge Funds Think About Rocket Pharmaceuticals, Inc. (RCKT)
"Market conditions are changing. The continued rise in interest rates suggests we are in the early stages of a bond bear market, which could intensify as central banks withdraw liquidity. The receding...
Three Biotech Investment Ideas from Cormorant Asset Management
The biotech industry is regaining ground it lost in 2016 at full speed. The sector was very hot until around mid-2015, with the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) gaining over 370% between...
Billionaire Hedge Funds
